Caitong International Asset Management »

Lineage Cell Therapeutics In shares owned by Caitong International Asset Management

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Caitong International Asset Management from 13F filings

Historical chart of Caitong International Asset Management investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Caitong International Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Caitong International Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $58 45 1.31
2026-03-31 $5 3 1.67

More positions owned by Caitong International Asset Management

Advanced Micro Devices (AMD)
Intel Corporation (INTC)
Corning Incorporated (GLW)
Strategy Cl A New (MSTR)
Apple (AAPL)
Asml Hldg Nv N Y Registry Shs (ASML)
Bloom Energy Corp Com Cl A (BE)
Oracle Corporation (ORCL)
Seagate Technology Hldngs Pl Ord Shs (STX)
Alphabet Cap Stk Cl A (GOOGL)
Kla Corp Com New (KLAC)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
ON Semiconductor (ON)
Cisco Systems (CSCO)

View all positions for Caitong International Asset Management

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
BlackRock
Vanguard Capital Management
Defender Capital
Geode Capital Management
Raffles Associates
Fifth Third Bancorp
Millennium Management
Morgan Stanley
Vanguard Fiduciary Trust
Northern Trust
Renaissance Technologies
Marshall Wace
Vanguard Portfolio Management
State Street Corporation

View all funds holding Lineage Cell Therapeutics In